Literature DB >> 20727363

Sensing G protein-coupled receptor activation.

Manuela Ambrosio1, Alexander Zürn, Martin J Lohse.   

Abstract

G protein-coupled receptors (GPCRs) are the key elements of a highly regulated transduction machinery that generates different signaling outcomes to hormones and neurotransmitters. Until recently, it was assumed that diverse ligands of a given GPCR differ only in their ability to alter the balance between the OFF and the ON state of the receptor. However, it has now become evident that their activation mechanisms are more complex and that receptors presumably display distinguishable active conformational states, which are induced by different agonists and correlate to specific signaling outputs. The use of different labeling strategies to insert fluorescent labels into purified, reconstituted receptors, or into receptors in intact cells, has made it possible to sense receptor activation via changes in their fluorescence. Here, we summarize recent progress in the analysis of agonist-dependent activation mechanisms of GPCRs acquired using modern spectroscopic and crystallographic techniques.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20727363     DOI: 10.1016/j.neuropharm.2010.08.006

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  15 in total

1.  Intramolecular fluorescence resonance energy transfer (FRET) sensors of the orexin OX1 and OX2 receptors identify slow kinetics of agonist activation.

Authors:  Tian-Rui Xu; Richard J Ward; John D Pediani; Graeme Milligan
Journal:  J Biol Chem       Date:  2012-03-02       Impact factor: 5.157

2.  Communication over the network of binary switches regulates the activation of A2A adenosine receptor.

Authors:  Yoonji Lee; Sun Choi; Changbong Hyeon
Journal:  PLoS Comput Biol       Date:  2015-02-09       Impact factor: 4.475

Review 3.  Olfaction under metabolic influences.

Authors:  Brigitte Palouzier-Paulignan; Marie-Christine Lacroix; Pascaline Aimé; Christine Baly; Monique Caillol; Patrice Congar; A Karyn Julliard; Kristal Tucker; Debra Ann Fadool
Journal:  Chem Senses       Date:  2012-07-25       Impact factor: 3.160

Review 4.  The prevalence, maintenance, and relevance of G protein-coupled receptor oligomerization.

Authors:  Graeme Milligan
Journal:  Mol Pharmacol       Date:  2013-04-30       Impact factor: 4.436

Review 5.  Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family.

Authors:  Joseph H Neale; Rafal T Olszewski; Daiying Zuo; Karolina J Janczura; Caterina P Profaci; Kaleen M Lavin; John C Madore; Tomasz Bzdega
Journal:  J Neurochem       Date:  2011-07-01       Impact factor: 5.372

Review 6.  Showcasing modern molecular dynamics simulations of membrane proteins through G protein-coupled receptors.

Authors:  Jennifer M Johnston; Marta Filizola
Journal:  Curr Opin Struct Biol       Date:  2011-07-19       Impact factor: 6.809

7.  N-acetylaspartylglutamate is an agonist at mGluR₃ in vivo and in vitro.

Authors:  Joseph H Neale
Journal:  J Neurochem       Date:  2011-12       Impact factor: 5.372

8.  Type 2 metabotropic glutamate receptor (mGluR2) fails to negatively couple to cGMP in stably transfected cells.

Authors:  Barbara Wroblewska; Iga N Wegorzewska; Tomasz Bzdega; Joseph H Neale
Journal:  Neurochem Int       Date:  2010-11-27       Impact factor: 3.921

9.  Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia.

Authors:  Caterina P Profaci; Kristyn A Krolikowski; Rafal T Olszewski; Joseph H Neale
Journal:  Psychopharmacology (Berl)       Date:  2011-02-16       Impact factor: 4.530

10.  Ligand-dependent activation and deactivation of the human adenosine A(2A) receptor.

Authors:  Jianing Li; Amanda L Jonsson; Thijs Beuming; John C Shelley; Gregory A Voth
Journal:  J Am Chem Soc       Date:  2013-05-29       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.